NeoGenomics
272 hedge funds and large institutions have $2.62B invested in NeoGenomics in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 88 increasing their positions, 106 reducing their positions, and 17 closing their positions.
88% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 17
12% more call options, than puts
Call options by funds: $6.85M | Put options by funds: $6.09M
4% more funds holding
Funds holding: 261 → 272 (+11)
0.84% more ownership
Funds ownership: 89.51% → 90.35% (+0.84%)
4% less capital invested
Capital invested by funds: $2.73B → $2.62B (-$119M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
17% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 106
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$46.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.4M |
| 3 |
FAM
Fred Alger Management
New York
|
+$17.6M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$11.3M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$27.7M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$21.8M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$20.3M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$10.9M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$8.95M |
NEO Hedge Fund Activity: Q1 2020 in Review
272 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2020, worth a combined $2.62B — down 4.4% from $2.73B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new NEO positions and 17 closed out — a net gain of 15 holders — while 88 added to existing stakes and 106 trimmed.
The largest buyer was Invesco, adding an estimated $46.9M. The largest seller was Granite Investment Partners, cutting an estimated $27.7M.
- 272 institutional investors held NeoGenomics (NEO) as of Q1 2020, up from 261 in Q4 2019.
- Funds reported $2.62B of NeoGenomics stock for Q1 2020, down 4.4% quarter-over-quarter.
- 32 funds opened new NeoGenomics positions in Q1 2020 and 17 closed out, a net change of +15 holders.
- The largest NeoGenomics buyer in Q1 2020 was Invesco, an estimated $46.9M added.
- The largest NeoGenomics seller in Q1 2020 was Granite Investment Partners, an estimated $27.7M sold.
Based on aggregated 13F filings for Q1 2020.